As shown in Figure 3E, although there was no significant correlation between GPX2 and MYH9 in clinical presentation, GCLC and GCLM were significantly upregulated in tumors, and their molecular levels were statistically correlated with MYH9 expression (p < 0.001 in GCLC-MYH9 and GCLM-MYH9). Here, GPX2 is linked to lung giant cell carcinoma.